Notably, immunohistochemistry using tissue sections from three different human melanomas (melanomas 1–3) revealed a significant proportion of melanoma cells exhibiting nuclear staining of TFEB (Figure S1C), suggesting that, in vivo, mTORC1 signaling is suppressed. Here, TFEB is linked to melanoma.